Cleared Traditional

K153022 - Philips IntelliSpace Cardiovascular

K153022 is an FDA 510(k) clearance for Philips IntelliSpace Cardiovascular, manufactured by Philips Medical Systems Nethrlands BV. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 34-day FDA review.

K153022 · Philips Medical Systems Nethrlands BV · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
34d
Days
Class 2
Risk

K153022 is an FDA 510(k) clearance for the Philips IntelliSpace Cardiovascular. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Medical Systems Nethrlands BV (Best Noord-Brabant, NL). The FDA issued a Cleared decision on November 18, 2015 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K153022

510(k) Number K153022 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 2015
Decision Date November 18, 2015
Days to Decision 34 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 107d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2229
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K153022.
Econsole1
K152172 · DRTECH Corporation · Dec 2015
Implant Studio 2015
K152078 · 3Shape Medical A/S · Dec 2015
VidiStar HeartView
K152822 · Vidistar, LLC · Nov 2015
HICAT Air
K152661 · Hicat GmbH · Nov 2015
UroNav (Version 2.0)
K153073 · Invivo Corporation · Nov 2015
Ziostation2
K151212 · Qi Imaging, LLC · Nov 2015